Literature DB >> 25777786

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.

B Pernas1, A Mena1, A Cañizares2, M Grandal1, A Castro-Iglesias1, S Pértega3, J D Pedreira1, E Poveda1.   

Abstract

To describe temporal trend and characteristics of newly HIV-diagnosed patients in a medical care area in Northwest Spain over the last 10 years. All newly diagnosed patients for HIV-infection from 2004 to 2013 at a reference medical care area in Northwest of Spain were identified. Epidemiological, virological, immunological, and clinical data, as well as HIV genotype and drug resistance information were recorded. A total of 565 newly HIV-diagnosed patients were identified. The number of new cases increased in the last 5 years (66 cases/year). Overall, 53.1% had a median CD4 counts < 350 cells/µl and 33.6% had an AIDS defining criteria. Non-B variants were found in 34.4% of patients being subtype F (25.8%) the most common non-B subtype. The rate of transmitted drug resistance (TDR) over the study period was 3.7%, but a decreased to 2.6% was observed in the last 5 years. The most prevalent TDR mutations were: T215 revertants (1.5%), K219QENR (1.2%), for NRTIs; K103N (1.9%), for NNRTIs; L90M (0.3%), for PIs. Overall, 73.2% of patients started antiretroviral treatment and 9.9% of patients died during follow-up. The number of newly HIV diagnosed patients increased since year 2009. There is a high prevalence of late diagnosis (53%) and 33% had an AIDS defining criteria. Interestingly, the most prevalent non-B subtype in our population was F (25.8%). These findings support the need to facilitate the access for HIV testing to reduce the rate of late HIV diagnosis, improve the clinical outcome and prevent HIV transmission.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV-1 genetic subtype; late diagnosis; newly HIV-diagnoses; transmitted drug resistance

Mesh:

Substances:

Year:  2015        PMID: 25777786     DOI: 10.1002/jmv.24185

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain.

Authors:  Santiago Pérez-Parra; Natalia Chueca; Marta Álvarez; Juan Pasquau; Mohamed Omar; Antonio Collado; David Vinuesa; Ana B Lozano; Gonzalo Yebra; Federico García
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

2.  Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015.

Authors:  Min Jung Kim; Hyun Ha Chang; Sang Il Kim; Youn Jeong Kim; Dae Won Park; Chun Kang; Mee Kyung Kee; Ju Yeon Choi; Soo Min Kim; Bo Youl Choi; Woo Joo Kim; June Myung Kim; Jun Yong Choi; Young Hwa Choi; Jin Soo Lee; Shin Woo Kim
Journal:  Infect Chemother       Date:  2017-06-01

3.  Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Authors:  Purificación Cid-Silva; Luis Margusino-Framiñán; Vanesa Balboa-Barreiro; Berta Pernas-Souto; Álvaro Mena-De-Cea; Isabel Martín-Herranz; Ángeles Castro-Iglesias; Eva Poveda
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.